SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹63 Cr | ₹59 Cr | ₹54 Cr | ₹47 Cr | ₹33 Cr |
What is the latest Total Current Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹63 Cr |
| Mar2024 | ₹59 Cr |
| Mar2023 | ₹54 Cr |
| Mar2022 | ₹47 Cr |
| Mar2021 | ₹33 Cr |
How is Total Current Liabilities of SAKAR HEALTHCARE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹63 Cr | 6.99 | |
| Mar2024 | ₹59 Cr | 8.38 | |
| Mar2023 | ₹54 Cr | 16.50 | |
| Mar2022 | ₹47 Cr | 40.60 | |
| Mar2021 | ₹33 Cr | - | |
Compare Total Current Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,948.5 Cr | 1.6% | 9.5% | 158.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 1.6% |
9.5% |
158.6% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses